EP 3904383 A1 20211103 - ANTI-OX40 MONOCLONAL ANTIBODY AND APPLICATION THEREOF
Title (en)
ANTI-OX40 MONOCLONAL ANTIBODY AND APPLICATION THEREOF
Title (de)
MONOKLONALER ANTI-OX40-ANTIKÖRPER UND ANWENDUNG DAVON
Title (fr)
ANTICORPS MONOCLONAL ANTI-OX40 ET UTILISATION ASSOCIÉE
Publication
Application
Priority
CN 2018123393 W 20181225
Abstract (en)
Provided in the present invention are an anti-OX40 monoclonal antibody or an antigen-binding fragment thereof, and a corresponding isolated polynucleotide, expression vector, recombinant cell, pharmaceutical composition, and application thereof. The present antibody can be used for the treatment of cancer or autoimmune disease.
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C12N 15/06 (2006.01); C12N 15/13 (2006.01); C12N 15/85 (2006.01)
CPC (source: EP US)
A61K 39/001129 (2018.08 - EP); A61K 45/06 (2013.01 - US); A61P 35/00 (2018.01 - EP US); A61P 37/04 (2018.01 - EP); C07K 16/2878 (2013.01 - EP US); C07K 16/30 (2013.01 - US); C12N 15/85 (2013.01 - US); A61K 2039/505 (2013.01 - EP US); C07K 2317/33 (2013.01 - EP); C07K 2317/75 (2013.01 - EP); C07K 2317/92 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3904383 A1 20211103; EP 3904383 A4 20220817; JP 2022517313 A 20220308; JP 7346576 B2 20230919; US 2022017632 A1 20220120; WO 2020132857 A1 20200702
DOCDB simple family (application)
EP 18945324 A 20181225; CN 2018123393 W 20181225; JP 2021537796 A 20181225; US 201817418145 A 20181225